• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    ICL Reports Third Quarter 2024 Results

    11/11/24 2:01:00 AM ET
    $ICL
    Agricultural Chemicals
    Industrials
    Get the next $ICL alert in real time by email

    Continued to deliver sequential growth, with sales of $1.8 billion and adjusted EBITDA of $383 million

    Raising guidance for specialties-driven businesses

    ICL (NYSE:ICL) (TASE: ICL), a leading global specialty minerals company, today reported its financial results for the third quarter ended September 30, 2024. Consolidated sales were $1.75 billion versus $1.86 billion in the prior year. Operating income was $214 million, with adjusted operating income of $243 million, versus $227 million of operating income in the third quarter of last year. Adjusted EBITDA was $383 million versus $346 million. Diluted earnings per share were $0.09, with adjusted diluted EPS of $0.11, versus $0.11 in the third quarter of last year.

    "ICL delivered another sequential increase in EBITDA, as well as versus the prior year, marking four consecutive quarters of improvement, despite lower potash prices. All three of our specialties-driven businesses showed significant year-over-year improvement in EBITDA, demonstrating the strength of our strategy and our ability to consistently deliver strong cash generation," said Raviv Zoller, president and CEO of ICL. "While we are still facing some challenges related to geopolitical uncertainties, we remain focused on developing our innovative product portfolio pipeline and executing targeted cost and efficiency efforts."

    The company raised its guidance for full year 2024 and now expects specialties-driven EBITDA of between $0.95 billion to $1.05 billion, an increase from previous guidance of $0.8 billion to $1.0 billion. The company intends to limit its total 2024 annual potash sales volumes to 4.6 million metric tons, already committed, which is in-line with 2023 sales volumes and in expectation of improved conditions in 2025. (1a)

    Key Financials

    Third Quarter 2024

    US$M

    Ex. per share data

    3Q'24

    3Q'23

    Sales

    $1,753

    $1,862

    Gross profit

    $596

    $586

    Gross margin

    34%

    31%

    Operating income

    $214

    $227

    Adjusted operating income (1)

    $243

    $227

    Operating margin

    12%

    12%

    Adjusted operating margin (1)

    14%

    12%

    Net income attributable to shareholders

    $113

    $137

    Adjusted net income attributable to shareholders (1)

    $136

    $137

    Adjusted EBITDA (1)(2)

    $383

    $346

    Adjusted EBITDA margin (1)(2)

    22%

    19%

    Diluted earnings per share

    $0.09

    $0.11

    Diluted adjusted earnings per share (1)

    $0.11

    $0.11

    Cash flows from operating activities (3)

    $408

    $426

    (1)

    Adjusted operating income and margin, adjusted net income attributable to shareholders, adjusted EBITDA and margin, and diluted adjusted earnings per share are non-GAAP financial measures. Please refer to the adjustments table and disclaimer.

    (2)

    In the nine months of 2024, the company's adjusted EBITDA was positively impacted by an immaterial accounting reclassification. Please refer to the 6-K filing for additional details.

    (3)

    Reclassified - see Note 2 to the company's interim financial statements.

    Industrial Products

    Third quarter 2024

    • Sales of $309 million vs. $267 million.
    • EBITDA of $65 million vs. $42 million.
    • Year-over-year growth driven by market share gains in flame retardants.

    Key developments versus prior year

    • Flame retardants: Sales increased, as higher volumes for both brominated- and phosphorous-based solutions offset lower prices overall, while demand from both the electronics and construction end-markets remained soft.
    • Elemental bromine: Higher volumes drove an increase in sales, offsetting lower prices.
    • Clear brine fluids: Sales declined, despite strength in the Gulf of Mexico, as oil and gas demand in the Eastern Hemisphere was lower, due to the normal pattern of the drilling operations cycle.
    • Specialty minerals: Increased sales were driven by higher volumes for industrial applications, while prices were lower.

    Potash

    Third quarter 2024

    • Sales of $389 million vs. $526 million.
    • EBITDA of $120 million vs. $164 million.
    • Grain Price Index decreased 19.6% year-over-year, with corn, rice, soybeans and wheat down 27.2%, 4.3%, 26.4% and 29.0%, respectively. On a sequential basis, the Grain Price Index decreased 14.3%, with corn, rice, soybeans and wheat down 11.5%, 16.4%, 11.9% and 14.1%, respectively.

    Key developments versus prior year

    • Potash price: $297 per ton (CIF).
      • Down 1% sequentially and 13% year-over-year.
    • Potash sales volumes: 1,060 thousand metric tons.
      • Decreased by 220 thousand metric tons year-over-year.
    • ICL Dead Sea
      • Production decreased, primarily due to external forces.
    • ICL Iberia
      • Record third quarter production, with continued operational and efficiency improvements.
    • Metal Magnesium
      • Both volumes and prices declined, as market prices continued to trend lower.

    Phosphate Solutions

    Third quarter 2024

    • Sales of $577 million vs. $595 million.
    • EBITDA of $140 million vs. $118 million.
    • Third sequential quarter of sales growth, with EBITDA up nearly 20% year-over-year.

    Key developments versus prior year

    • White phosphoric acid: Sales decreased, as higher volumes in most regions were unable to offset lower prices in Europe, as well as in North and South America.
    • Industrial phosphates: Sales increased, as higher volumes in all major regions offset lower prices related to decreasing cost inputs.
    • Food phosphates: Despite higher volumes, sales decreased due to lower market prices, which reflected reduced raw material costs.
    • Battery materials: China sales increased, as market demand expanded there. Elsewhere, the company continued to execute on its long-term battery materials strategy, with the U.S. customer innovation and qualification center (CIQC) on-track for completion by year-end. The business also expanded into South America, with the addition of a new customer.
    • Commodity phosphates: Overall phosphate prices firmed in the third quarter, with tight stock positions in key markets, strategic allocation decisions and prevailing policies.

    Growing Solutions

    Third quarter 2024

    • Sales of $538 million vs. $550 million.
    • EBITDA of $64 million vs. $37 million.
    • Third sequential quarter of sales and EBITDA growth, with EBITDA up more than 70% year-over-year.

    Key developments versus prior year

    • Brazil: Sales declined, due to exchange rate fluctuations, but higher prices and lower raw material costs drove an increase in gross profit.
    • Europe: Sales decreased, but gross profit increased on higher volumes and lower raw material costs.
    • North America: Sales increased, with higher volumes and slightly higher prices contributing to increased gross profit.
    • Asia: Sales increased, and higher volumes, prices and product mix drove higher gross profit.
    • Product trends: Specialty agriculture sales decreased, as exchange rate fluctuations, mainly in Brazil, and lower sales volumes in China offset higher prices. Turf and ornamental sales increased, with both turf and landscape and ornamental horticulture contributing.

    Financial Items

    Financing Expenses

    Net financing expenses for the third quarter of 2024 were $39 million, down versus $42 million in the corresponding quarter of last year.

    Tax Expenses

    Reported tax expenses in the third quarter of 2024 were $49 million, reflecting an effective tax rate of 28%, compared to $43 million in the corresponding quarter of last year, reflecting an effective tax rate of 23%. The lower tax rate in the third quarter of last year was mainly due to the devaluation of the shekel versus the U.S. dollar.

    Available Liquidity

    ICL's available cash resources, which are comprised of cash and deposits, unutilized revolving credit facility, and unutilized securitization, totaled $1,749 million, as of September 30, 2024.

    Outstanding Net Debt

    As of September 30, 2024, ICL's net financial liabilities amounted to $1,948 million, a decrease of $147 million compared to December 31, 2023.

    Dividend Distribution

    In connection with ICL's third quarter 2024 results, the Board of Directors declared a dividend of 5.27 cents per share, or approximately $68 million, versus 5.31 cents per share, or approximately $68 million, in the third quarter of last year. The dividend will be payable on December 18, 2024, to shareholders of record as of December 4, 2024.

    About ICL

    ICL Group Ltd. is a leading global specialty minerals company, which creates impactful solutions for humanity's sustainability challenges in the food, agriculture and industrial markets. ICL leverages its unique bromine, potash and phosphate resources, its global professional workforce, and its sustainability focused R&D and technological innovation capabilities, to drive the company's growth across its end markets. ICL shares are dual listed on the New York Stock Exchange and the Tel Aviv Stock Exchange (NYSE and TASE: ICL). The company employs more than 12,000 people worldwide, and its 2023 revenue totaled approximately $7.5 billion.

    For more information, including ICL's full third quarter financial statements and report, visit ICL's website at icl-group.com, and also the SEC's EDGAR website, once it reopens on November 12, 2024.

    To access ICL's interactive CSR report, visit icl-group-sustainability.com.

    You can also learn more about ICL on Facebook, LinkedIn, YouTube, X and Instagram.

    Guidance

    (1a) The company only provides guidance on a non-GAAP basis. The company does not provide a reconciliation of forward-looking adjusted EBITDA (non-GAAP) to GAAP net income (loss), due to the inherent difficulty in forecasting, and quantifying certain amounts that are necessary for such reconciliation, in particular, because special items such as restructuring, litigation, and other matters, used to calculate projected net income (loss) vary dramatically based on actual events, the company is not able to forecast on a GAAP basis with reasonable certainty all deductions needed in order to provide a GAAP calculation of projected net income (loss) at this time. The amount of these deductions may be material, and therefore could result in projected GAAP net income (loss) being materially less than projected adjusted EBITDA (non-GAAP). The guidance speaks only as of the date hereof. The company undertakes no obligation to update any of these forward-looking statements to reflect events or circumstances after the date of this news release or to reflect actual outcomes, unless required by law. The company provides guidance for specialties-driven EBITDA, which includes Industrial Products, Growing Solutions and Phosphate Solutions, as the Phosphate Solutions business is now predominantly specialties focused. For the Potash business, the company is providing sales volume guidance. The company believes this information provides greater transparency, as these new metrics are less impacted by fertilizer commodity prices, given the extreme volatility in recent years.

    Non-GAAP Statement

    The company discloses in this quarterly report non-IFRS financial measures titled adjusted operating income, adjusted net income attributable to the company's shareholders, diluted adjusted earnings per share, and adjusted EBITDA. Management uses adjusted operating income, adjusted net income attributable to the company's shareholders, diluted adjusted earnings per share, and adjusted EBITDA to facilitate operating performance comparisons from period to period. The company calculates adjusted operating income by adjusting operating income to add certain items, as set forth in the reconciliation table under "Adjustments to reported operating, and net income (non-GAAP)" below. Certain of these items may recur. The company calculates adjusted net income attributable to the company's shareholders by adjusting net income attributable to the company's shareholders to add certain items, as set forth in the reconciliation table under "Adjustments to reported operating, and net income (non-GAAP)" below, excluding the total tax impact of such adjustments. The company calculates diluted adjusted earnings per share by dividing adjusted net income by the weighted-average number of diluted ordinary shares outstanding. Adjusted EBITDA is calculated as net income before financing expenses, net, taxes on income, share in earnings of equity-accounted investees, depreciation and amortization, and certain adjustments presented in the reconciliation table under "Consolidated adjusted EBITDA, and diluted adjusted earnings per share for the periods of activity" below, which were adjusted for in calculating the adjusted operating income.

    You should not view adjusted operating income, adjusted net income attributable to the company's shareholders, diluted adjusted earnings per share or adjusted EBITDA as a substitute for operating income or net income attributable to the company's shareholders determined in accordance with IFRS, and you should note that the company's definitions of adjusted operating income, adjusted net income attributable to the company's shareholders, diluted adjusted earnings per share, and adjusted EBITDA may differ from those used by other companies. Additionally, other companies may use other measures to evaluate their performance, which may reduce the usefulness of the company's non-IFRS financial measures as tools for comparison. However, the company believes adjusted operating income, adjusted net income attributable to the company's shareholders, diluted adjusted earnings per share, and adjusted EBITDA provide useful information to both management, and investors by excluding certain items that management believes are not indicative of ongoing operations. Management uses these non-IFRS measures to evaluate the company's business strategies and management performance. The company believes these non‑IFRS measures provide useful information to investors because they improve the comparability of financial results between periods and provide for greater transparency of key measures used to evaluate performance.

    The company presents a discussion in the period-to-period comparisons of the primary drivers of change in the company's results of operations. This discussion is based in part on management's best estimates of the impact of the main trends on the company's businesses. The company has based the following discussion on its financial statements. You should read such discussion together with the company's financial statements.

    Forward Looking Statements

    This announcement contains statements that constitute "forward‑looking statements," many of which can be identified by the use of forward‑looking words such as "anticipate," "believe," "could," "expect," "should," "plan," "intend," "estimate," "strive," "forecast," "targets" and "potential," among others. The company is relying on the safe harbor provided in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, in making such forward-looking statements.

    Forward‑looking statements appear in a number of places in this announcement and include, but are not limited to, statements regarding intent, belief or current expectations. Forward‑looking statements are based on management's beliefs and assumptions and on information currently available to management. Such statements are subject to risks and uncertainties and actual results may differ materially from those expressed or implied in the forward‑looking statements due to various factors, including, but not limited to:

    Loss or impairment of business licenses or mineral extractions permits or concessions; volatility of supply and demand and the impact of competition; the difference between actual reserves and reserve estimates; natural disasters and cost of compliance with environmental regulatory legislative and licensing restrictions including laws and regulation related to, and physical impacts of climate change and greenhouse gas emissions; failure to "harvest" salt which could lead to accumulation of salt at the bottom of the evaporation Pond 5 in the Dead Sea; litigation, arbitration and regulatory proceedings; disruptions at seaport shipping facilities or regulatory restrictions affecting the ability to export products overseas; changes in exchange rates or prices compared to those the company is currently experiencing; general market, political or economic conditions in the countries in which the company operates; price increases or shortages with respect to principal raw materials; pandemics may create disruptions, impacting sales, operations, supply chain and customers; delays in termination of engagements with contractors and/or governmental obligations; the inflow of significant amounts of water into the Dead Sea which could adversely affect production at the plants; labor disputes, slowdowns and strikes involving employees; pension and health insurance liabilities; changes to governmental incentive programs or tax benefits, creation of new fiscal or tax related legislation; and/or higher tax liabilities; changes in evaluations and estimates, which serve as a basis for the recognition and manner of measurement of assets and liabilities; failure to integrate or realize expected benefits from mergers and acquisitions, organizational restructuring and joint ventures; currency rate fluctuations; rising interest rates; government examinations or investigations; information technology systems or breaches of the company, or its service providers', data security; failure to retain and/or recruit key personnel; inability to realize expected benefits from the company's cost reduction program according to the expected timetable; inability to access capital markets on favorable terms; cyclicality of the businesses; the company is exposed to risks relating to its current and future activity in emerging markets; changes in demand for its fertilizer products due to a decline in agricultural product prices, lack of available credit, weather conditions, government policies or other factors beyond the company's control; disruption of the company, or its service providers', sales of magnesium products being affected by various factors that are not within the company's control; volatility or crises in the financial markets; hazards inherent to mining and chemical manufacturing; the failure to ensure the safety of the company's workers and processes; exposure to third party and product liability claims; product recalls or other liability claims as a result of food safety and food-borne illness concerns; insufficiency of insurance coverage; war or acts of terror and/or political, economic and military instability in Israel and its region, including the current state of war declared in Israel and any resulting disruptions to supply and production chains; filing of class actions and derivative actions against the company, its executives and Board members; closing of transactions, mergers and acquisitions; and other risk factors discussed under "Item 3 - Key Information— D. Risk Factors" in the company's Annual Report on Form 20-F for the year ended December 31, 2023, filed with the U.S. Securities and Exchange Commission (SEC) on March 14, 2024 (the Annual Report).

    Forward‑looking statements speak only as of the date they are made, and, except as otherwise required by law, the company does not undertake any obligation to update them in light of new information or future developments or to release publicly any revisions to these statements, targets or goals in order to reflect later events or circumstances or to reflect the occurrence of unanticipated events. Investors are cautioned to consider these risk and uncertainties and to not place undue reliance on such information. Forward-looking statements should not be read as a guarantee of future performance or results and are subject to risks and uncertainties, and the actual results may differ materially from those expressed or implied in the forward-looking statements.

    This report for the third quarter of 2024 should be read in conjunction with the Annual Report of 2023 published by the company on Form 20-F and the report for the first and second quarters of 2024 published by the company, including the description of events occurring subsequent to the date of the statement of financial position, as filed with the US SEC.

    Appendix

    Condensed Consolidated Statements of Income (Unaudited)

    $ millions

    Three-months ended

    Nine-months ended

    Year ended

     

    September 30,

    2024

    September 30,

    2023

    September 30,

    2024

    September 30,

    2023

    December 31,

    2023

    Sales

    1,753

    1,862

    5,240

    5,846

    7,536

    Cost of sales

    1,157

    1,276

    3,519

    3,735

    4,865

     

     

     

     

     

     

    Gross profit

    596

    586

    1,721

    2,111

    2,671

     

     

     

     

     

     

    Selling, transport and marketing expenses

    280

    264

    833

    807

    1,093

    General and administrative expenses

    63

    66

    191

    189

    260

    Research and development expenses

    19

    17

    50

    54

    71

    Other expenses

    22

    14

    27

    84

    128

    Other income

    (2)

    (2)

    (8)

    (15)

    (22)

     

     

     

     

     

     

    Operating income

    214

    227

    628

    992

    1,141

     

     

     

     

     

     

    Finance expenses

    46

    79

    166

    255

    259

    Finance income

    (7)

    (37)

    (59)

    (120)

    (91)

    Finance expenses, net

    39

    42

    107

    135

    168

     

     

     

     

     

     

    Share in earnings of equity-accounted investees

    1

    -

    1

    -

    1

     

     

     

     

     

     

    Income before taxes on income

    176

    185

    522

    857

    974

     

     

     

     

     

     

    Taxes on income

    49

    43

    139

    254

    287

     

     

     

     

     

     

    Net income

    127

    142

    383

    603

    687

     

     

     

     

     

     

    Net income attributable to the non-controlling interests

    14

    5

    46

    23

    40

     

     

     

     

     

     

    Net income attributable to the shareholders of the Company

    113

    137

    337

    580

    647

     

     

     

     

     

     

    Earnings per share attributable to the shareholders of the Company:

     

     

     

     

     

     

     

     

     

     

     

    Basic earnings per share (in dollars)

    0.09

    0.11

    0.26

    0.45

    0.50

     

     

     

     

     

     

    Diluted earnings per share (in dollars)

    0.09

    0.11

    0.26

    0.45

    0.50

     

     

     

     

     

     

    Weighted-average number of ordinary shares outstanding:

     

     

     

     

     

     

     

     

     

     

     

    Basic (in thousands)

    1,290,171

    1,289,318

    1,289,869

    1,289,332

    1,289,361

     

     

     

     

     

     

    Diluted (in thousands)

    1,290,371

    1,290,813

    1,290,094

    1,290,926

    1,290,668

     

    Condensed Consolidated Statements of Financial Position as of (Unaudited)

    $ millions

     

    September 30,

    2024

     

    September 30,

    2023

     

    December 31,

    2023

    Current assets

     

     

     

     

     

     

    Cash and cash equivalents

     

    393

     

    307

     

    420

    Short-term investments and deposits

     

    110

     

    162

     

    172

    Trade receivables

     

    1,393

     

    1,387

     

    1,376

    Inventories

     

    1,591

     

    1,722

     

    1,703

    Prepaid expenses and other receivables

     

    337

     

    362

     

    363

    Total current assets

     

    3,824

     

    3,940

     

    4,034

     

     

     

     

     

     

     

    Non-current assets

     

     

     

     

     

     

    Deferred tax assets

     

    149

     

    141

     

    152

    Property, plant and equipment

     

    6,414

     

    6,125

     

    6,329

    Intangible assets

     

    916

     

    851

     

    873

    Other non-current assets

     

    255

     

    217

     

    239

    Total non-current assets

     

    7,734

     

    7,334

     

    7,593

     

     

     

     

     

     

     

    Total assets

     

    11,558

     

    11,274

     

    11,627

     

     

     

     

     

     

     

    Current liabilities

     

     

     

     

     

     

    Short-term debt

     

    606

     

    592

     

    858

    Trade payables

     

    921

     

    814

     

    912

    Provisions

     

    49

     

    71

     

    85

    Other payables

     

    874

     

    809

     

    783

    Total current liabilities

     

    2,450

     

    2,286

     

    2,638

     

     

     

     

     

     

     

    Non-current liabilities

     

     

     

     

     

     

    Long-term debt and debentures

     

    1,845

     

    1,984

     

    1,829

    Deferred tax liabilities

     

    495

     

    464

     

    489

    Long-term employee liabilities

     

    339

     

    334

     

    354

    Long-term provisions and accruals

     

    223

     

    234

     

    224

    Other

     

    71

     

    64

     

    56

    Total non-current liabilities

     

    2,973

     

    3,080

     

    2,952

     

     

     

     

     

     

     

    Total liabilities

     

    5,423

     

    5,366

     

    5,590

     

     

     

     

     

     

     

    Equity

     

     

     

     

     

     

    Total shareholders' equity

     

    5,873

     

    5,664

     

    5,768

    Non-controlling interests

     

    262

     

    244

     

    269

    Total equity

     

    6,135

     

    5,908

     

    6,037

     

     

     

     

     

     

     

    Total liabilities and equity

     

    11,558

     

    11,274

     

    11,627

     

    Condensed Consolidated Statements of Cash Flows (Unaudited)

    $ millions

     

    Three-months ended

     

    Nine-months ended

     

    Year ended

     

     

    September 30,

    2024

     

    September 30,

    2023

     

    September 30,

    2024

     

    September 30,

    2023

     

    December 31,

    2023

    Cash flows from operating activities

     

     

     

     

     

     

     

     

     

     

    Net income

     

    127

     

    142

     

    383

     

    603

     

    687

    Adjustments for:

     

     

     

     

     

     

     

     

     

     

    Depreciation and amortization

     

    140

     

    119

     

    439

     

    390

     

    536

    Fixed assets impairment

     

    7

     

    -

     

    7

     

    -

     

    -

    Exchange rate, interest and derivative, net

     

    9

     

    27

     

    105

     

    75

     

    24

    Tax expenses

     

    49

     

    43

     

    139

     

    254

     

    287

    Change in provisions

     

    -

     

    (13)

     

    (53)

     

    (41)

     

    (32)

    Other

     

    2

     

    1

     

    6

     

    7

     

    29

     

     

    207

     

    177

     

    643

     

    685

     

    844

     

     

     

     

     

     

     

     

     

     

     

    Change in inventories

     

    (14)

     

    251

     

    95

     

    415

     

    465

    Change in trade receivables

     

    73

     

    (28)

     

    (42)

     

    205

     

    252

    Change in trade payables

     

    46

     

    (59)

     

    17

     

    (167)

     

    (101)

    Change in other receivables

     

    (31)

     

    (6)

     

    (27)

     

    (11)

     

    26

    Change in other payables

     

    22

     

    (19)

     

    4

     

    (226)

     

    (210)

    Net change in operating assets and liabilities

     

    96

     

    139

     

    47

     

    216

     

    432

     

     

     

     

     

     

     

     

     

     

     

    Income taxes paid, net of refund

     

    (22)

     

    (32)

     

    (57)

     

    (246)

     

    (253)

     

     

     

     

     

     

     

     

     

     

     

    Net cash provided by operating activities (*)

     

    408

     

    426

     

    1,016

     

    1,258

     

    1,710

     

     

     

     

     

     

     

     

     

     

     

    Cash flows from investing activities

     

     

     

     

     

     

     

     

     

     

    Proceeds (payments) from deposits, net

     

    -

     

    1

     

    61

     

    (78)

     

    (88)

    Purchases of property, plant and equipment and intangible assets

     

    (159)

     

    (191)

     

    (446)

     

    (525)

     

    (780)

    Interest received (*)

     

    4

     

    2

     

    14

     

    7

     

    10

    Proceeds from divestiture of assets and businesses, net of transaction expenses

     

    1

     

    1

     

    19

     

    4

     

    4

    Business combinations

     

    (50)

     

    -

     

    (72)

     

    -

     

    -

    Other

     

    -

     

    -

     

    -

     

    1

     

    1

    Net cash used in investing activities

     

    (204)

     

    (187)

     

    (424)

     

    (591)

     

    (853)

     

     

     

     

     

     

     

     

     

     

     

    Cash flows from financing activities

     

     

     

     

     

     

     

     

     

     

    Dividends paid to the Company's shareholders

     

    (63)

     

    (82)

     

    (183)

     

    (406)

     

    (474)

    Receipts of long-term debt

     

    273

     

    131

     

    611

     

    484

     

    633

    Repayments of long-term debt

     

    (307)

     

    (255)

     

    (919)

     

    (653)

     

    (836)

    Receipts (Repayments) of short-term debt

     

    8

     

    (72)

     

    7

     

    (89)

     

    (25)

    Interest paid (*)

     

    (16)

     

    (21)

     

    (79)

     

    (85)

     

    (125)

    Receipts (payments) from transactions in derivatives

     

    (2)

     

    -

     

    1

     

    6

     

    5

    Dividend paid to the non-controlling interests

     

    -

     

    -

     

    (57)

     

    (15)

     

    (15)

    Net cash used in financing activities

     

    (107)

     

    (299)

     

    (619)

     

    (758)

     

    (837)

     

     

     

     

     

     

     

     

     

     

     

    Net change in cash and cash equivalents

     

    97

     

    (60)

     

    (27)

     

    (91)

     

    20

    Cash and cash equivalents as of the beginning of the period

     

    287

     

    372

     

    420

     

    417

     

    417

    Net effect of currency translation on cash and cash equivalents

     

    9

     

    (5)

     

    -

     

    (19)

     

    (17)

    Cash and cash equivalents as of the end of the period

     

    393

     

    307

     

    393

     

    307

     

    420

     

    (*) Reclassified - see Note 2 to the Company's Interim Financial Statements.

    Adjustments to Reported Operating and Net Income (non-GAAP)

    $ millions

     

    Three-months ended

     

    Nine-months ended

     

    September 30,

    2024

     

    September 30,

    2023

     

    September 30,

    2024

     

    September 30,

    2023

    Operating income

     

    214

     

    227

     

    628

     

    992

    Charges related to the security situation in Israel (1)

     

    14

     

    -

     

    40

     

    -

    Write-off of assets and provision for site closure (2)

     

    15

     

    -

     

    15

     

    15

    Total adjustments to operating income

     

    29

     

    -

     

    55

     

    15

    Adjusted operating income

     

    243

     

    227

     

    683

     

    1,007

    Net income attributable to the shareholders of the Company

     

    113

     

    137

     

    337

     

    580

    Total adjustments to operating income

     

    29

     

    -

     

    55

     

    15

    Total tax adjustments (3)

     

    (6)

     

    -

     

    (12)

     

    (3)

    Total adjusted net income - shareholders of the Company

     

    136

     

    137

     

    380

     

    592

     

    (1)

    For 2024, reflects charges relating to the security situation in Israel.

    (2)

    For 2024, reflects mainly a write-off of assets resulting from the closure of two small sites. For 2023, reflects mainly a write-off of assets related to restructuring at certain sites, including site closures and facility modifications, as part of the Company's global efficiency plan.

    (3)

    For 2024 and 2023, reflects the tax impact of adjustments made to operating income.

    Consolidated EBITDA for the Periods of Activity

    $ millions

     

    Three-months ended

     

    Nine-months ended

     

     

    September 30,

    2024

     

    September 30,

    2023

     

    September 30,

    2024

     

    September 30,

    2023

    Net income

     

    127

     

    142

     

    383

     

    603

    Financing expenses, net

     

    39

     

    42

     

    107

     

    135

    Taxes on income

     

    49

     

    43

     

    139

     

    254

    Less: Share in earnings of equity-accounted investees

     

    (1)

     

    -

     

    (1)

     

    -

    Operating income

     

    214

     

    227

     

    628

     

    992

    Depreciation and amortization

     

    140

     

    119

     

    439

     

    390

    Adjustments (1)

     

    29

     

    -

     

    55

     

    15

    Total adjusted EBITDA (2)

     

    383

     

    346

     

    1,122

     

    1,397

     

    (1)

    See "Adjustments to Reported Operating and Net income (non-GAAP)" above.

    (2)

    In the first nine months of 2024, the Company's adjusted EBITDA was positively impacted by an immaterial accounting reclassification. Please refer to the 6-K filing for additional details.

    Calculation of Segment EBITDA

    $ millions

     

    Industrial Products

     

    Potash

     

    Phosphate Solutions (1)

     

    Growing Solutions

     

     

    Three-months ended

     

     

    September 30,

    2024

     

    September 30,

    2023

     

    September 30,

    2024

     

    September 30,

    2023

     

    September 30,

    2024 (2)

     

    September 30,

    2023

     

    September 30,

    2024

     

    September 30,

    2023

    Segment operating income

     

    50

     

    31

     

    59

     

    125

     

    100

     

    73

     

    49

     

    20

    Depreciation and amortization

     

    15

     

    11

     

    61

     

    39

     

    40

     

    45

     

    15

     

    17

    Segment EBITDA

     

    65

     

    42

     

    120

     

    164

     

    140

     

    118

     

    64

     

    37

     

    (1)

    In alignment with the Company's efficiency plan, which includes a change of reporting responsibilities as of January 2024, the results of a non-phosphate related business were allocated from the Phosphate Solutions segment to Other Activities. Comparative figures have been restated to reflect the organizational change in the reportable segments.

    (2)

    For Q3 2024, Phosphate Specialties comprised $331 million of segment sales, $49 million of operating income, $12 million of D&A and represented $61 million of EBITDA, while Phosphate Commodities comprised $246 million of segment sales, $51 million of operating income, $28 million of D&A and represented $79 million of EBITDA.

     

    View source version on businesswire.com: https://www.businesswire.com/news/home/20241110145727/en/

    Get the next $ICL alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $ICL

    DatePrice TargetRatingAnalyst
    1/21/2025$4.00 → $6.00Underweight → Equal Weight
    Barclays
    1/12/2024$6.50 → $4.00Overweight → Underweight
    Barclays
    11/14/2023$7.00 → $6.50Equal Weight → Overweight
    Barclays
    5/18/2023Buy → Neutral
    BofA Securities
    6/1/2022$12.00Equal Weight
    Barclays
    2/14/2022$9.00 → $10.00Equal-Weight
    Morgan Stanley
    12/6/2021$7.00 → $9.00Equal-Weight
    Morgan Stanley
    More analyst ratings

    $ICL
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • ICL Reports First Quarter 2025 Results

      Sales of $1.8 billion increased year-over-year, with operating income of $185 million, adjusted EBITDA of $359 million and adjusted diluted EPS of $0.09 ICL (NYSE:ICL) (TASE: ICL), a leading global specialty minerals company, today reported its financial results for the first quarter ended March 31, 2025. Consolidated sales were $1.8 billion versus $1.7 billion in the prior year. Operating income was $185 million versus $203 million of operating income in the first quarter of last year, with adjusted operating income of $208 million versus $215 million. For the first quarter, net income attributable to shareholders was $91 million versus $109 million in the prior year, with adjusted net in

      5/19/25 1:10:00 AM ET
      $ICL
      Agricultural Chemicals
      Industrials
    • ICL Announces First Quarter 2025 Earnings Call

      ICL (NYSE:ICL) (TASE: ICL), a leading global specialty minerals company, today announced it plans to release first quarter 2025 results prior to the opening of the TASE market on Monday, May 19, 2025. On that day, Elad Aharonson, president and CEO of ICL, and Aviram Lahav, CFO of ICL, will host a conference call to discuss results, provide a general business update and answer questions at 8:30 a.m. New York time (1:30 p.m. London and 3:30 p.m. Tel Aviv). The dial-in number for financial analysts in North America is (800) 549-8228, or (646) 564-2877 for international analysts, and the conference ID is ICL. To participate, please dial in a few minutes before the scheduled time. Employees,

      4/23/25 8:00:00 AM ET
      $ICL
      Agricultural Chemicals
      Industrials
    • Israel Corp. Reports Results for Fourth Quarter of 2024

      TEL AVIV, Israel, March 27, 2025 /PRNewswire/ -- Israel Corporation Ltd. (TASE: ILCO) ("ILCO") announced today its fourth quarter and annual results for the period ending December 31, 2024. Selected Financial Figures for the Fourth Quarter 2024: $m Q3/24 Q3/23 2024 2023 ILCO share in ICL profit1 30 28 175 282 Financing, G&A and other at ILCO headquarter level  2 1 - (8) Tax income (expense) of ILCO Headquarters (1) (1) 15 (1) Net profit to company's shareholders 31 28 190 273 Liquidity at the ILCO Headquarters Level2 As of December 31, 2024, total financial liabilities were $733 million, and investments in liquid assets amounted to $882 million of which $83 million are pledged deposits. Net

      3/27/25 5:48:00 PM ET
      $ICL
      Agricultural Chemicals
      Industrials

    $ICL
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by ICL Group Ltd.

      SC 13G/A - ICL Group Ltd. (0000941221) (Subject)

      11/14/24 6:11:02 AM ET
      $ICL
      Agricultural Chemicals
      Industrials
    • SEC Form SC 13G filed by ICL Group Ltd.

      SC 13G - ICL Group Ltd. (0000941221) (Subject)

      1/31/24 6:05:59 AM ET
      $ICL
      Agricultural Chemicals
      Industrials
    • SEC Form SC 13G/A filed by ICL Group Ltd. (Amendment)

      SC 13G/A - ICL Group Ltd. (0000941221) (Subject)

      1/30/24 8:10:40 AM ET
      $ICL
      Agricultural Chemicals
      Industrials

    $ICL
    Leadership Updates

    Live Leadership Updates

    See more
    • ICL Announces Appointment of Elad Aharonson as New President and Chief Executive Officer

      ICL (NYSE:ICL) (TASE: ICL), a leading global specialty minerals company, today announced its Board of Directors has approved the appointment of Elad Aharonson as ICL's new president and chief executive officer, effective March 13, 2025. He will succeed Raviv Zoller who will work with Aharonson to ensure a smooth and orderly transition. Elad Aharonson has been an integral part of ICL for nearly four years, serving as president of ICL's Growing Solutions business since April of 2021. During his tenure, he led the development of ICL's specialty fertilizer solutions and the expansion of these product offerings into new territories, through both organic efforts and via acquisitions. His signif

      12/23/24 2:10:00 AM ET
      $ICL
      Agricultural Chemicals
      Industrials
    • ICL Announces Planned Departure of President and CEO Raviv Zoller

      Zoller to continue to serve the company until a replacement has been announced ICL (NYSE:ICL) (TASE: ICL), a leading global specialty minerals company, today announced that Raviv Zoller, the company's president and CEO for the past seven years, is expected to leave the company in early 2025, following both the appointment of a replacement and a formal transition. In a letter to the company's employees, Zoller wrote, "I feel great pride, mixed with sorrow, as I announce my expected retirement from the position as president and CEO of ICL. Over the past seven years at this amazing organization, I have come to know our employees who give their heart and soul to the company. Together, we ha

      12/5/24 7:21:00 AM ET
      $ICL
      Agricultural Chemicals
      Industrials
    • ICL Recognized by Fortune as a Company That is Changing the World

      Company's Agmatix AI-driven data platform and RegenIQ framework designated as a Friend of Farmers ICL (NYSE:ICL) (TASE: ICL), a leading global specialty minerals company, today announced that Agmatix, the company's ag tech digital start-up, has been named to Fortune's 10th Annual Change the World list. The list recognizes companies that have had a positive social impact through activities that are part of their core business strategy. Among other factors, nominees are assessed on their measurable impact on people and the planet, profitability related to their impactful work, and the degree of innovation they have demonstrated. Agmatix was recognized for its AI-driven platform, which helps

      10/15/24 4:15:00 PM ET
      $ICL
      Agricultural Chemicals
      Industrials

    $ICL
    SEC Filings

    See more
    • SEC Form 6-K filed by ICL Group Ltd.

      6-K - ICL Group Ltd. (0000941221) (Filer)

      5/20/25 4:20:09 PM ET
      $ICL
      Agricultural Chemicals
      Industrials
    • SEC Form 6-K filed by ICL Group Ltd.

      6-K - ICL Group Ltd. (0000941221) (Filer)

      5/19/25 2:51:00 PM ET
      $ICL
      Agricultural Chemicals
      Industrials
    • SEC Form 6-K filed by ICL Group Ltd.

      6-K - ICL Group Ltd. (0000941221) (Filer)

      5/19/25 6:50:24 AM ET
      $ICL
      Agricultural Chemicals
      Industrials

    $ICL
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • ICL Group upgraded by Barclays with a new price target

      Barclays upgraded ICL Group from Underweight to Equal Weight and set a new price target of $6.00 from $4.00 previously

      1/21/25 7:50:33 AM ET
      $ICL
      Agricultural Chemicals
      Industrials
    • ICL Group downgraded by Barclays with a new price target

      Barclays downgraded ICL Group from Overweight to Underweight and set a new price target of $4.00 from $6.50 previously

      1/12/24 6:56:19 AM ET
      $ICL
      Agricultural Chemicals
      Industrials
    • ICL Group upgraded by Barclays with a new price target

      Barclays upgraded ICL Group from Equal Weight to Overweight and set a new price target of $6.50 from $7.00 previously

      11/14/23 7:37:49 AM ET
      $ICL
      Agricultural Chemicals
      Industrials

    $ICL
    Financials

    Live finance-specific insights

    See more
    • ICL Reports First Quarter 2025 Results

      Sales of $1.8 billion increased year-over-year, with operating income of $185 million, adjusted EBITDA of $359 million and adjusted diluted EPS of $0.09 ICL (NYSE:ICL) (TASE: ICL), a leading global specialty minerals company, today reported its financial results for the first quarter ended March 31, 2025. Consolidated sales were $1.8 billion versus $1.7 billion in the prior year. Operating income was $185 million versus $203 million of operating income in the first quarter of last year, with adjusted operating income of $208 million versus $215 million. For the first quarter, net income attributable to shareholders was $91 million versus $109 million in the prior year, with adjusted net in

      5/19/25 1:10:00 AM ET
      $ICL
      Agricultural Chemicals
      Industrials
    • ICL Announces First Quarter 2025 Earnings Call

      ICL (NYSE:ICL) (TASE: ICL), a leading global specialty minerals company, today announced it plans to release first quarter 2025 results prior to the opening of the TASE market on Monday, May 19, 2025. On that day, Elad Aharonson, president and CEO of ICL, and Aviram Lahav, CFO of ICL, will host a conference call to discuss results, provide a general business update and answer questions at 8:30 a.m. New York time (1:30 p.m. London and 3:30 p.m. Tel Aviv). The dial-in number for financial analysts in North America is (800) 549-8228, or (646) 564-2877 for international analysts, and the conference ID is ICL. To participate, please dial in a few minutes before the scheduled time. Employees,

      4/23/25 8:00:00 AM ET
      $ICL
      Agricultural Chemicals
      Industrials
    • Israel Corp. Reports Results for Fourth Quarter of 2024

      TEL AVIV, Israel, March 27, 2025 /PRNewswire/ -- Israel Corporation Ltd. (TASE: ILCO) ("ILCO") announced today its fourth quarter and annual results for the period ending December 31, 2024. Selected Financial Figures for the Fourth Quarter 2024: $m Q3/24 Q3/23 2024 2023 ILCO share in ICL profit1 30 28 175 282 Financing, G&A and other at ILCO headquarter level  2 1 - (8) Tax income (expense) of ILCO Headquarters (1) (1) 15 (1) Net profit to company's shareholders 31 28 190 273 Liquidity at the ILCO Headquarters Level2 As of December 31, 2024, total financial liabilities were $733 million, and investments in liquid assets amounted to $882 million of which $83 million are pledged deposits. Net

      3/27/25 5:48:00 PM ET
      $ICL
      Agricultural Chemicals
      Industrials